CONTIMED II BIOFEEDBACK DEV TREAT OF URIN INCONTI— 510(k) K891774

Substantially Equivalent

Hollister, Inc.

FDA 510(k) clearance K891774 for CONTIMED II BIOFEEDBACK DEV TREAT OF URIN INCONTI, Substantially Equivalent on 1989-08-23. Applicant: Hollister, Inc..

Clearance details

Applicant: Hollister, Inc.
Product code: Code HIR
Advisory panel: Obstetrics/Gynecology
Date received: 1989-03-24
Decision date: 1989-08-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Libertyville, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.